Venture capital fund · 34 deals
Sydney, NSW
Every published round OneVentures took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies OneVentures has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| 2021 - Series A | 2023 Series A+ | Retail analytics and foot traffic tracking software | Feb 2022, Series B | 1 | 1 |
| AMP | 11 Mar 2025 | 1 | 0 | |
| BiVACOR | May 2018, Series A | 1 | 0 | |
| BuildKite | 17 Nov 2022, Series B | 1 | 1 | |
| Coassemble | 19 Feb 2021, Venture debt | 1 | 1 | |
| Employment Hero | Mar 2018, Series B | 6 | 0 | |
| Eucalyptus | 27 Jan 2022, Series C | 1 | 0 | |
| Flippa | 20 Sep 2021, Series A | 1 | 1 | |
| Hivery | 15 Jul 2022, Series B | 1 | 0 | |
| Hometime | 2019, Venture debt | 3 | 0 | |
| ImmVirX | Jun 2023, undisclosed | 1 | 0 | |
| InDebted | 8 Feb 2021, Venture debt | 2 | 0 | |
| Kepler Analytics | 23 Feb 2022, Series B | 1 | 1 | |
| Lumary | 30 Mar 2021 | 1 | 1 | |
| MyPass | 17 Feb 2025, Series A | 1 | 1 | |
| Phocas | Jun 2018 | 2 | 0 | |
| Phocas Software | 29 Jan 2021 | 1 | 0 | |
| Shippit | 1 Dec 2019 | 1 | 0 | |
| Vaxxas | 4 Aug 2011, Series A | 4 | 3 | |
| Zoomo | Aug 2021, Venture debt | 3 | 0 |
Companies OneVentures's own portfolio page lists that no published round yet places it in. The page is the source; the round is being looked for.
| Company | Site |
|---|---|
| 6clicks | - |
| AmazingCo | - |
| Biza.io | - |
| BuildingIQ | - |
| Cascade | - |
| Charm Health | - |
| Dataweavers | - |
| Drawboard | - |
| EatClub | - |
| Edrolo | - |
| etrainu | - |
| Find-Me Technologies | - |
| Fleet Space Technologies | - |
| Investor Log in | dynamo.dynamosoftware.com ↗ |
Fund closes reported for OneVentures, as distinct from the investments it has made.
| Fund | Announced | Committed | Target | Close | Sources |
|---|---|---|---|---|---|
| 1V Venture Credit fund | 20 Dec 2020 | $80m | - | Final | Startup Daily, SmartCompany (Tue 15 Dec 2020), SmartCompany (Fri 18 Sep 2020), SmartCompany (Tue 15 Sep 2020) |
| OneVentures Growth Fund V | 6 Dec 2020 | $75m | $200m | Interim | SmartCompany, Startup Daily, OneVentures portfolio |
| 1V Venture Credit Fund | 22 Jul 2020 | ~$80m | - | Final | SmartCompany, Startup News (WA), OneVentures portfolio (Wed 5 Aug 2020), OneVentures portfolio (Wed 22 Jul 2020) |
| Venture Credit Fund | 16 Apr 2019 | $45m | - | Interim | SmartCompany (Thu 20 Jun 2019), SmartCompany (Tue 16 Apr 2019), OneVentures portfolio |
| 1V Venture Credit Fund | Aug 2018 | $100m | - | - | Startup Daily, SmartCompany |
Investors that coverage says has money in a fund OneVentures runs. This is a stake in the fund, not in any company the fund has backed.
| Investor | Fund | Sources |
|---|---|---|
| Australian Government | OneVentures Innovation Fund | GBS Ventures (Thu 12 Dec 2013), GBS Ventures (Thu 31 Oct 2013), GBS Ventures (Fri 2 Dec 2011) |
| Australian Government | OneVentures Innovation Fund I | Brandon Capital, Brandon BioCatalyst portfolio, Brandon Capital portfolio (Thu 19 Jan 2023), Brandon Capital portfolio (Wed 9 Nov 2022) |
| OneVentures | Venture Growth Fund | Women's Agenda, SmartCompany |
| Victorian Government | Venture Growth Fund | Women's Agenda, SmartCompany |
This is a stake in the fund itself, money that the fund's manager invests, not a stake in the fund manager.
| Fund | Manager | Sources |
|---|---|---|
| Venture Growth Fund | OneVentures | Women's Agenda, SmartCompany |
Companies OneVentures has backed that another company then bought. An exit for the holding, not a deal OneVentures did.
| Company | Bought by | Kind | Announced | Price |
|---|---|---|---|---|
| Eucalyptus | Hims & Hers | Acquisition | Jan 2026 | $1.6b |
| Phocas | Accel-KKR | Acquisition | 15 Oct 2025 | $500m+ |
Stories naming OneVentures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASIC filings show Buildkite raised $21m via convertible debt in January 2026 after heavy losses and a CEO change; its earlier backers include OneVentures, AirTree, General Catalyst and Dom Pym.
Also Capital Brief
Roundup of six Australian funding deals: AutoGrab, Applied EV, Checkbox, Hometime, Factory and On the House, with amounts, investors, and Hometime's past acquisitions and raise history detailed.
Also Startup Daily
Sydney short-stay property manager Hometime has secured $19 million in fresh equity and debt, led by Verona Capital with Commonwealth Bank refinancing; the piece also recounts earlier raises and three rival acquisitions.
Smart50 profile ranks leadership coaching firm Peeplcoach 45th, noting its Melbourne head office, founders Christine Khor and James Chisholm, and more than $3 million raised over five years from individual backers.
Curated OneVentures roundup: Eucalyptus sold to a New York-listed healthcare group for $1.6 billion and Vaxxas named ex-Merck vaccines president David Peacock as CEO, plus patent-cliff and women-in-tech links.
Weekly roundup detailing five Australian raises: Vaxxas' Series D plus debt facility amid executive changes, Skutopia's growth round, Send Payments' backing and CEO change, Apate.ai's seed, and Coursebox's seed.
Also Startup Daily·SmartCompany·Australian FinTech·Dealroom·Startup Daily
Australian biotech Vaxxas secured a Series D plus a debt facility while overhauling leadership: a new chair, founding CEO shifting to an advisory role, and CFO made redundant amid job cuts.
Also Business News Australia·SmartCompany·Cut Through Venture·Startup Daily·Startup Daily·SmartCompany·Startup Daily
Vaxxas announced a roughly A$90m financing — Series D equity led by SPRIM Global Investments plus debt — to advance its needle-free vaccine patch, alongside leadership changes including a new chair.
A OneVentures blog post flags an artificial heart developer it has backed as out soliciting fresh capital; the text provided names no company, investors, or completed round.
AFR reports the titanium artificial heart maker is chasing $100 million for trials after a Sydney patient spent three months on the device; OneVentures is named as a backer.
E-commerce software firm AMP raised $20 million from Openspace Ventures and OneVentures and bought Back in Stock, a Shopify restocking app, adding its 25,000 customers; its 2023 Series A was $29.5 million.
Sydney workforce-credential platform MyPass Global has closed a $7.5 million Series A round led by venture firm OneVentures, with funds earmarked for product development and growth across the Americas.
Weekly roundup of seven Australian and New Zealand raises totalling $42.8 million, spanning property-investment AI, workforce credentialing, allied-health practice software, conversation analytics, maths learning games, copper processing and holiday-park bookings.
Vaxxas has finished enrolling 258 volunteers in its Phase I trial of a needle-free HD-MAP avian flu vaccine, funded by a US BARDA contract, with early findings due mid-2025.
Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·labonline.com.au·SmartCompany·labonline.com.au
Vaxxas has filled its 258-person Phase I trial of a needle-free avian flu vaccine patch, run under a US$28.5 million US government contract; the post also recounts the company's early backing.
Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·labonline.com.au·SmartCompany·labonline.com.au
Workforce credentialing platform MyPass has secured $7.5 million in Series A backing from OneVentures to grow across the Americas and further build its Skills Passport product. Scalare Partners seeded the company in 2020.
Also SmartCompany
Vaxxas has won the concept stage of BARDA's Patch Forward Prize, earning US$2 million (A$3.2 million) to progress its microarray patch vaccine platform alongside the University of Queensland's BASE facility.
Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·labonline.com.au·SmartCompany·labonline.com.au
Vaxxas wins US$2 million as a concept-stage winner of BARDA's prize to advance its skin-patch vaccine platform with UQ's BASE facility; the article also recalls early backing by OneVentures, Brandon Capital and HealthCare Ventures.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·@AuManufacturing·@AuManufacturing·Business News Australia
Employment Hero acquires Canada's Humi for $112m and, filings show, paid $43.4m for Ben Thompson's Employment Innovations; the story also recalls its 2023 Series F and investor clash.
A OneVentures blog stub links to Capital Brief's report that the venture firm is approaching a major growth milestone, has added key staff, and is preparing a fresh fund.
SYNthesis BioVentures' third investor letter reports a roughly A$7.5m first close for Alzheimer's biotech S2N, lists co-investors, and profiles managing director Amir's career across OneVentures, Ceres Capital and other life-sciences roles.
The venture firm's own post says it is out raising for a new vehicle to fill space corporate investors have vacated; the text states no close and no committed amount.
OneVentures' media-roundup page archives press coverage of the firm and of Employment Hero's major funding round, while its headline funds-under-management milestone remains an intention rather than a completed close.
Hometime, a Sydney platform managing Airbnb properties, has banked $10m from Fifth Estate Asset Management to fund acquisitions, adding two directors; earlier raises and rival takeovers are also recalled.
Weekly roundup of seven trans-Tasman raises totalling $27.4 million, headlined by Xefco's $10.5 million round, plus Hometime board appointments and Matrak's China expansion.
Also Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily
Buildkite announces a US$21 million Series B with Airtree and OneVentures leading; founder Keith Pitt reflects on nine years building the company, its Test Analytics product, and plans for new developer tools.
Roundup of the week's funding news: nine companies across Australia and New Zealand secured investment spanning clean energy, construction logistics, legal tech, coaching, research tools, creator media, medtech and marketing software.
Also Startup Daily·SmartCompany·SmartCompany·SmartCompany·SmartCompany·LaunchVic
Leadership coaching platform Peeplcoach has raised $1.3 million from backers including Jacinta McDonell and LaunchVic's Alice Anderson Fund, funding local and overseas expansion and taking its total raised beyond $3 million.
Roundup of January 2024 funding: Futurerent, Prota Therapeutics, National Renewable Network and Getmee together secured $94.5 million across debt, equity and a government grant, with investor details for each deal.
Prota Therapeutics, a Melbourne biotech, has secured $32 million in equity and debt ahead of a Phase 3 trial of its peanut allergy therapy, with Singapore's SPRIM Global Investments leading the round.
Also SmartCompany·SmartCompany·SmartCompany·Business News Australia·Forbes Australia
OneVentures realised $116.2 million selling its Employment Hero stake in a secondary deal, and its managing director Michelle Deaker is leaving the HR platform's chair role while staying on the board.
Publisher's post about a venture firm multiplying its money thirteen-fold on one startup bet; the page also carries linked reports of Eucalyptus's $1.6 billion sale and Vaxxas naming David Peacock chief executive.
US regulators cleared first-in-human testing of BiVACOR's total artificial heart; the OneVentures page also links earlier coverage and the Biomedical Translation Fund's investment in the device.
Vaxxas reports positive Phase I results for its needle-free skin-patch delivery of a measles-rubella vaccine, with Gates Foundation grant funding and a planned PATH-sponsored Phase I/II trial in The Gambia.
Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·labonline.com.au·SmartCompany·labonline.com.au
Blog announcement of Employment Hero's 263 million Australian dollar Series F, with TCV leading and Insight Partners, AirTree, Seek and OneVentures also participating; the post also unveils the Hero Foundation.
Also Tech Funding News - Australia·TechCrunch Venture·SmartCompany·Startup Daily·Techboard·SmartCompany·Startup Daily·Forbes Australia·Forbes Australia·employmenthero.com·TechCrunch Venture
Press release announcing Employment Hero's A$263 million Series F led by TCV, with earlier backers participating, a valuation just under $2 billion, AI-focused global expansion plans, and a look back at the KeyPay acquisition.
Also Tech Funding News - Australia·TechCrunch Venture·SmartCompany·Startup Daily·Techboard·SmartCompany·Startup Daily·Forbes Australia·Forbes Australia·employmenthero.com·TechCrunch Venture
Employment Hero raised a $263 million Series F led by TCV, reaching a $2 billion valuation, with existing backers reinvesting; Skykraft announced a $120 million raise.
Australian HR software firm Employment Hero has banked a large Series F led by US investor TCV, lifting its valuation towards $2 billion, with several existing backers also taking part.
Sydney HR-and-payroll firm Employment Hero announced a TCV-led Series F reaching unicorn valuation; the profile covers its products, remote workforce and global ambitions, citing rival raises.
Also Tech Funding News - Australia·TechCrunch Venture·SmartCompany·Startup Daily·Techboard·SmartCompany·Startup Daily·Forbes Australia·Forbes Australia·employmenthero.com·employmenthero.com
Partner content profiles an AI ecommerce startup that used OneVentures venture debt instead of equity to drive growth, also recalling its $10 million Series A from 2021.